Nutrigenomics: Where Nutrition Meets DNA – The Future of Personalized Health

 The global nutrigenomics market size is expected to reach USD 1.4 billion by 2030 registering a CAGR of 17.4% from 2024 to 2030 according to a new report by Grand View Research, Inc. This growth can be attributed to the rising cases of obesity and Cardiovascular Diseases (CVDs), particularly in developed regions. Nutrigenomics can play a vital role in the prevention of obesity by offering personalized, gene-based diet. Increased awareness about the product along with growing geriatric population will also augment the market growth.

 

Obesity and cancer research applications of nutrigenomics emerged as the market leaders in 2023 and are expected to maintain the dominance expanding at a significant CAGR over the forecast period. Developing regional markets including Asia Pacific, Latin America, and Middle East are also expected to witness rapid expansion owing to the increased cases of obesity and growing geriatric population.


Nutrigenomics Market Report Highlights


  • The global nutrigenomics market size was valued at USD 448.2 million in 2023 and is projected to grow at a CAGR of 17.4% from 2024 to 2030
  • Obesity application segment led the market in 2023 and is estimated to account for a 38% of the industry share by 2030
  • Cancer research is projected to be the fastest-growing application of nutrigenomics over the forecast period, registering a CAGR of 18.0%.
  • North America accounted for the largest market share in 2023 and is estimated to maintain its dominance over the years to come
  • Asia Pacific nutrigenomics market is expected to experience the fastest growth of 18.1%, driven by the increasing prevalence of chronic diseases such as diabetes, obesity, and heart disease


Nutrigenomics Market Segmentation


Grand View Research has segmented the global nutrigenomics market report based on application, product, technique, end use, and region:


Nutrigenomics Application Outlook (Revenue, USD Million, 2018 - 2030)


  • Obesity
  • Cardiovascular Diseases
  • Cancer Research
  • Others


Nutrigenomics Product Outlook (Revenue, USD Million, 2018 - 2030)


  • Reagents & Kits
  • Services


Nutrigenomics Technique Outlook (Revenue, USD Million, 2018 - 2030)


  • Saliva
  • Buccal Swab
  • Blood


Nutrigenomics End Use Outlook (Revenue, USD Million, 2018 - 2030)


  • Hospitals & Clinics
  • Others


Nutrigenomics Regional Outlook (Revenue, USD Million, 2018 - 2030)


  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait



Key Players in the Nutrigenomics Market

 

  • Nutrigenomix
  • The Gene Box
  • Metagenics
  • Xcode Life
  • GX Sciences, LLC (Fagron)
  • Cura Integrative Medicine
  • dnalife
  • Genova Diagnostics (GDX)
  • HOLISTIC HEALTH INTERNATIONAL, LLC

 

 

Order a free sample PDF of the Nutrigenomics Market Intelligence Study, published by Grand View Research.

 

Comments

Post a Comment

Popular posts from this blog

Exploring the Rapid Growth of the Aerogel Market: Trends and Forecasts for 2024

  Aerogel Industry Overview   The global aerogel market size is expected to reach USD 3.49 billion by 2030, registering a CAGR of 17.0% from 2025 to 2030, according to a new report by Grand View Research, Inc. Aerogel has a wide application portfolio due to its unique qualities and ongoing research & development regarding its usage in new and advanced applications. Its properties including superior thermal resistance, lightweight, very low density, fire resistance, and excellent thermal insulation are likely to boost its demand across varied applications.   Aerogels can provide innovative and environment-friendly solutions for high-performance insulation and light-diffusing in a wide range of architectural daylighting applications. Major players offer advanced and innovative solutions for architectural applications. For instance, Cabot Corporation provides LUMIRA aerogel an innovative high-performance insulation for architectural daylighting. T...
Read more

Automotive Electronics Market size is expected to reach USD 468.17 billion by 2030

  Automotive Electronics Industry Overview The global automotive electronics market size was valued at USD 262.60 billion in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 8.8% from 2024 to 2030. The increasing integration and implementation of advanced safety systems such as automatic emergency braking, airbags, parking assistance systems, and lane departure warning to decrease road accidents is expected to favor demand over the forecast period. Moreover, features such as emergency call systems, alcohol ignition interlocks, and accident data recorder systems are rapidly adopted to safeguard in-vehicle passengers and are expected to drive market growth over the forecast period.   Gather more insights about the market drivers, restrains and growth of the   Automotive Electronics Market   The increasing demand for electric vehicles is driving the demand for automotive electronics. Many people are switching from fuel ignited vehi...
Read more

Global Active Pharmaceutical Ingredients Market to Reach $359.45 Billion by 2030

  Active Pharmaceutical Ingredients (API) Market Growth & Trends The global  active pharmaceutical ingredients (API) market  is expected to reach a valuation of USD 359.45 billion by 2030, growing at a compound annual growth rate (CAGR) of 5.85% from 2025 to 2030, according to a recent report by Grand View Research, Inc. This growth is primarily driven by the rapid expansion of the biopharmaceutical sector, continuous technological advancements in API manufacturing, and the rising aging population, which is leading to a greater demand for pharmaceuticals globally. One of the key growth drivers is the increasing investment in captive API production, where pharmaceutical companies focus on developing in-house manufacturing capabilities. By doing so, companies can reduce costs, ensure quality control, and mitigate the risk of contamination associated with outsourcing. Advances in artificial intelligence (AI) and protein synthesis technologies are further streamlining API...
Read more